Dermal delivery of desmopressin acetate using colloidal carrier systems

Journal of Pharmacy and Pharmacology

Volumn 57, Issue 4, 2005, Pages 423-427

  Getie, Melkamu ^a   Wohlrab, Johannes ^a   Neubert, Reinhard H H ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOPRESSIN; DESMOPRESSIN ACETATE; DRUG CARRIER; WATER OIL CREAM;

ANALYTIC METHOD; ARTICLE; BREAST; CELL COMPARTMENTALIZATION; COLLOID; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; HUMAN; HUMAN TISSUE; INTESTINE MUCOSA; MICROEMULSION; SKIN PENETRATION; STRATUM CORNEUM;

ADMINISTRATION, CUTANEOUS; CHEMISTRY, PHARMACEUTICAL; DEAMINO ARGININE VASOPRESSIN; DRUG CARRIERS; EMULSIONS; HUMANS; OINTMENTS; SKIN ABSORPTION;

EID: 17144427716     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357055713     Document Type: Article

References (32)

1. Boltri, L., Morel, S., Trotta, M., Gasco, M. R. (1994) In vitro transdermal permeation of nifedipine from thickened microemulsions. J. Pharm. Belg. 49: 315-320
2. Cattaneo, M., Tenconi, P. M., Alberca, I., Garcia, V. V., Mannucci, P. M. (1990) Subcutaneous desmopressin (DDAVP) shortens the prolonged bleeding time in patients with liver cirrhosis. Thromb. Haemost. 64: 358-360
3. Cormier, M., Johnson, B., Ameri, M., Nyam, K., Libiran, L., Zhang, D. D., Daddona, P. (2004) Transdermal delivery of desmopressin using a coated microneedle array patch system. J. Control. Release 97: 503-511
4. de Gennes, P. G., Taupin, D. C. (1982) Microemulsions and the flexibility of oil/water interfaces. J. Phys. Chem. 86: 2294-2304
5. Delgado-Charro, M. B., Iglesias-Vilas, G., Blanco-Mendez, J., Lopez-Quintela, M. A., Guy, R. H. (1997) Delivery of hydrophilic solute through the skin from novel microemulsion systems. Eur. J. Pharm. Biopharm. 43: 37-42
6. Dreher, F., Walde, P., Walther, P., Wehrli, E. (1997) Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport. J. Control. Release 45: 131-140
7. Fjellestad-Paulsen, A., Hoglund, P., Lundin, S., Paulsen, O. (1993) Pharmacokinetics of 1-deamino-8-D-arginine vasopressin after various routes of administration in healthy volunteers. Clin. Endocrinol. 38: 177-182
8. Franz, T. J. (1975) Percutaneous absorption: on the relevance of in vitro data. J. Invest. Dermatol. 64: 190-195
9. Freidman, D. I., Amidon, G. L. (1991) Oral absorption of peptides: influence of pH and inhibitors on the intestinal hydrolysis of leuenkephalin and analogues. Pharm. Res. 8: 93-96
10. Getie, M., Neubert, R. H. H. (2004) LC-MS determination of desmopressin acetate in human skin samples. J. Pharm. Biomed. Anal. 35: 921-927
11. Gratz, I., Koehler, J., Olsen, D., Afshar, M., DeCastro, N., Spagna, P. M., Ablaza, S. G., Larijani, G. E. (1992) The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. J. Thorac. Cardiovasc. Surg. 104: 1417-1422
12. Harris, D., Robinson, J. R. (1990) Bioadhesive polymers in peptide drug delivery. Biomaterials 11: 652-657
13. Hsu, L. R., Tsai, Y. H., Huang, Y. B. (1991) The effect of pretreatment by penetration enhancers on the in vivo percutaneous absorption of piroxicam from its gel form in rabbits. Int. J. Pharm. 71: 193-200
14. Kanikkannan, N. (2002) Iontophoresis-based transdermal delivery systems. BioDrugs 16: 339-347
15. Langevin, D. (1992) Micelles and microemulsions. Ann. Rev. Phys. Chem. 43: 341-369
16. Lee, V. H. L. (1991) Changing needs in drug delivery in the era of peptide and protein drugs. In: Lee, V. H. L. (ed) Peptide and protein drug delivery. Marcel Dekker, New York, pp 1-56
17. Lee, V. H. L., Dodda-Kashi, S., Grass, G. M., Rubas, W. (1991) Oral route of peptide and protein drug delivery. In: Lee, V. H. L. (ed) Peptide and protein drug delivery. Marcel Dekker, New York, pp 691-738
18. Malmsten, M. (1998) Microemulsions in pharmaceuticals. In: Kumar, P., Mittal, K. L. (eds) Handbook of microemulsion science and technology. Marcel Dekker, New York, pp 755-771
19. Miller, K., Atkin, B., Moody, M. L. (1992) Drug therapy for nocturnal enuresis: current treatment recommendations. Drugs 44: 47-56
20. Morgan, T. M., O'Sullivan, H. M., Reed, B. L., Finnin, B. C. (1998) Transdermal delivery of estradiol in postmenopausal women with a novel topical aerosol. J. Pharm. Sci. 87: 1226-1228
21. Pillai, O., Borkute, S. D., Sivaprasad, N., Panchagnula, R. (2003) Transdermal iontophoresis of insulin. II. Physicochemical considerations. Int. J. Pharm. 254: 271-280
22. Robbins, P. B., Oliver, S. F., Sheu, S. M., Goodnough, J. B., Wender, P., Khavari, P. A. (2002) Peptide delivery to tissues via reversibly linked protein transduction sequences. Biotechniques 33: 190-194
23. Rose, E. H., Aledort, L. M. (1991) Nasal spray desmopressin (DDAVP) for mild hemophilia A and von Willebrand disease. Ann. Intern. Med. 114: 563-568
24. Shulman, L. H., Miller, J. L., Rose, L. I. (1990) Desmopressin for diabetes insipidus, hemostatic disorders and enuresis. Am. Fam. Physician 42: 1051-1057
25. Tao, S. L., Desai, T. A. (2003) Microfabricated drug delivery systems: from particles to pores. Adv. Drug Deliv. Rev. 55: 315-328
26. Trotta, M., Gasco, M. R., Morel, S. (1989) Release of drugs from oil-water microemulsions. J. Control. Release 10: 237-243
27. Trotta, M., Pattarino, F., Gasco, M. R. (1996) Influence of counter ions on the skin permeation of methotrexate from water-oil microemulsions. Pharm. Acta Helv. 71: 135-140
28. Trotta, M., Morel, S., Gasco, M. R. (1997) Effect of oil phase composition on the skin permeation of felodipine from o/w microemulsions. Pharmazie 52: 50-53
29. Vavra, I., Machova, A., Holecek, V., Cort, J. J., Zaoral, M., Sorm, F. (1968) Effect of a synthetic analogue of vasopressin in animals and in patients with diabetes insipidus. Lancet 1: 948-952
30. Vilhardt, H., Lundin, S. (1986) Biological effect and plasma concentrations of DDAVP after intranasal and peroral administration to humans. Gen. Pharmacol. 17: 481-483
31. Williams, A. C., Barry, B. W. (1992) Skin absorption enhancers. Crit. Rev. Ther. Drug Carrier Syst. 9: 305-353
32. Yamamoto, A., Setoh, K., Murakami, M., Shironoshita, M., Kobayashi, T., Fujimoto, K., Okada, N., Fujita, T., Muranishi, S. (2003) Enhanced transdermal delivery of phenylalanyl-glycine by chemical modification with various fatty acids. Int. J. Pharm. 250: 119-128